ZA943996B - Imidazopyridines - Google Patents

Imidazopyridines

Info

Publication number
ZA943996B
ZA943996B ZA943996A ZA943996A ZA943996B ZA 943996 B ZA943996 B ZA 943996B ZA 943996 A ZA943996 A ZA 943996A ZA 943996 A ZA943996 A ZA 943996A ZA 943996 B ZA943996 B ZA 943996B
Authority
ZA
South Africa
Prior art keywords
imidazopyridines
Prior art date
Application number
ZA943996A
Other languages
English (en)
Inventor
Mathias Osswald
Dieter Dorsch
Norbert Beier
Klaus-Otto Minck
Werner Mederski
Schelling Pierre
Ingeborg Lues
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA943996B publication Critical patent/ZA943996B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA943996A 1993-06-07 1994-06-07 Imidazopyridines ZA943996B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4318813A DE4318813A1 (de) 1993-06-07 1993-06-07 Imidazopyridine

Publications (1)

Publication Number Publication Date
ZA943996B true ZA943996B (en) 1995-02-06

Family

ID=6489765

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943996A ZA943996B (en) 1993-06-07 1994-06-07 Imidazopyridines

Country Status (16)

Country Link
US (1) US5438063A (show.php)
EP (1) EP0628556A1 (show.php)
JP (1) JPH072854A (show.php)
KR (1) KR950000697A (show.php)
CN (1) CN1100721A (show.php)
AU (1) AU689468B2 (show.php)
CA (1) CA2125077A1 (show.php)
CZ (1) CZ137694A3 (show.php)
DE (1) DE4318813A1 (show.php)
HU (1) HUT71483A (show.php)
NO (1) NO942095L (show.php)
PL (1) PL303715A1 (show.php)
RU (1) RU94019981A (show.php)
SK (1) SK67794A3 (show.php)
TW (1) TW269689B (show.php)
ZA (1) ZA943996B (show.php)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2708612B1 (fr) * 1993-08-05 1996-03-01 Roussel Uclaf Nouveaux dérivés bicycliques de l'imidazole, leur procédé de préparation, les nouveaux intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant.
DE4432860A1 (de) * 1994-09-15 1996-03-21 Merck Patent Gmbh Imidazopyridine
CN1221259C (zh) * 1996-07-15 2005-10-05 三共株式会社 Cs－866、氯沙坦和坎迪沙坦用于制备治疗动脉硬化的药物
DE19845153A1 (de) * 1998-10-01 2000-04-06 Merck Patent Gmbh Imidazo[4,5]-pyridin-4-on-derivate
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
AU2003284001A1 (en) 2002-10-07 2004-05-04 Bristol-Myers Squibb Company Triazolone and triazolethione derivatives
JP4970048B2 (ja) 2003-12-22 2012-07-04 カトリーケ・ウニフェルジテイト・ルーベン・カー・イュー・ルーベン・アール・アンド・ディ イミダゾ［４，５−ｃ］ピリジン化合物および抗ウイルス治療の方法
DE602005013580D1 (de) * 2004-12-21 2009-05-07 Leuven K U Res & Dev Imidazoä4,5-cüpyridinverbindung und verfahren zur antiviralen behandlung
DK1863801T3 (da) * 2005-03-30 2010-11-15 Takeda Pharmaceutical Benzimidazolderivat og anvendelse deraf
TWI360549B (en) 2006-07-07 2012-03-21 Gilead Sciences Inc Novel pyridazine compound and use thereof
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
WO2009158309A2 (en) * 2008-06-25 2009-12-30 Ligand Pharmaceuticals Inc. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
WO2009156889A1 (en) * 2008-06-25 2009-12-30 Pfizer Inc. Diaryl compounds and uses thereof
CN102037000A (zh) 2008-07-08 2011-04-27 株式会社钟化 α-杂取代烷基卤代氢硅烷的制造方法及其应用
CZ306650B6 (cs) * 2011-03-04 2017-04-19 Zentiva, K.S. Způsob výroby 2-ethoxy-1-((2´-((hydroxyamino)iminomethyl)bifenyl-4-yl)methyl)-1H-benzo[d]imidazol-7-karboxylové kyseliny a jejích esterů, klíčových intermediátů syntézy azilsartanu
US9617246B2 (en) 2013-12-18 2017-04-11 Merck Sharp & Dohme Corp. Thioether-piperidinyl orexin receptor antagonists
CN105669495A (zh) * 2014-11-21 2016-06-15 重庆朗天制药有限公司 一种阿奇沙坦及其中间体新的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5332744A (en) * 1989-05-30 1994-07-26 Merck & Co., Inc. Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
US5223499A (en) * 1989-05-30 1993-06-29 Merck & Co., Inc. 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
EP0430709A3 (en) * 1989-12-01 1992-02-12 Glaxo Group Limited Benzthiophen derivatives
DE4110019C2 (de) * 1991-03-27 2000-04-13 Merck Patent Gmbh Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
DE4141788A1 (de) * 1991-12-18 1993-06-24 Merck Patent Gmbh Imidazopyridine
DE4305602A1 (de) * 1992-06-17 1993-12-23 Merck Patent Gmbh Imidazopyridine

Also Published As

Publication number Publication date
HUT71483A (en) 1995-11-28
PL303715A1 (en) 1995-01-09
AU6348794A (en) 1994-12-08
CZ137694A3 (en) 1994-12-15
US5438063A (en) 1995-08-01
NO942095D0 (no) 1994-06-06
NO942095L (no) 1994-12-08
SK67794A3 (en) 1995-02-08
EP0628556A1 (de) 1994-12-14
KR950000697A (ko) 1995-01-03
RU94019981A (ru) 1996-06-10
HU9401692D0 (en) 1994-09-28
DE4318813A1 (de) 1994-12-08
CN1100721A (zh) 1995-03-29
JPH072854A (ja) 1995-01-06
AU689468B2 (en) 1998-04-02
CA2125077A1 (en) 1994-12-08
TW269689B (show.php) 1996-02-01

Similar Documents

Publication Publication Date Title
HU9403364D0 (en) Imidazopyridine
ZA939433B (en) Imidazopyridines
DE69426415D1 (en) Intrapulmonares hormonabgabesystem
DE69401926D1 (en) Hydroxamsäurederivate
ZA949664B (en) Imidazopyridines
HU9401692D0 (en) Imidazopyridines
DE59407177D1 (en) 2-fluorcycloyhexen-derivate
DE69423875D1 (en) Hydrodealkylierungsverfahren
GB9405560D0 (en) Aquameter
ZA942543B (en) Tetrohydro beta-carbolines
ZA932459B (en) Imidazopyridines
DE69408437D1 (en) Oxychlorierungsverfahren
GB2281166B (en) Telecines
ZA937875B (en) Imidazopyridines
GB2283157B (en) Swimfeeder
GB2274048B (en) Headcollars
DE69412128D1 (en) Kühlcontainer
ZA931368B (en) Sulphonylbenzyl-substituted imidazopyridines
DE69327259D1 (en) Signalmetrikabschätzer
ZA94990B (en) New imidazopyridines
GB2275091B (en) Nail-bolt
IL119547A0 (en) Imidazopyridine compounds
CA73639S (en) Handstamp
DE69409638D1 (en) 2-methylbutoxyethoxyethanol
ZA9410409B (en) Pyrazolopyridine compound